KL
Kalaris Therapeutics Inc (KLRS)
NASDAQ·Healthcare·Biotechnology
$3.16
-2.47%
Mkt Cap $65.65M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$18.00
Range $14.00 – $23.00
Implied Upside
+469.6%
Consensus $18.00 vs current $3.16
NASDAQ·Healthcare·Biotechnology
$3.16
-2.47%
Mkt Cap $65.65M
No recent rating data.
Price Target (5 analysts)
$18.00
Range $14.00 – $23.00
+469.6%
Consensus $18.00 vs current $3.16